Skip to main content
Normal View

Medicinal Products Reimbursement

Dáil Éireann Debate, Tuesday - 23 January 2018

Tuesday, 23 January 2018

Questions (373, 374)

Billy Kelleher

Question:

373. Deputy Billy Kelleher asked the Minister for Health the status of the introduction of the drug Ocrevus to the reimbursement scheme; if a date for introduction has been established; and if he will make a statement on the matter. [2957/18]

View answer

Billy Kelleher

Question:

374. Deputy Billy Kelleher asked the Minister for Health if consideration will be given to the request to introduce a pilot reimbursement scheme to allow Ocrevus to be brought to persons as soon as possible; and if he will make a statement on the matter. [2958/18]

View answer

Written answers

I propose to take Questions Nos. 373 and 374 together.

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Top
Share